Journal of Feline Medicine and Surgery (JFMS) – defining and advancing feline medicine and surgery.
JFMS is an international, peer-reviewed journal, and an official journal of both the International Society of Feline Medicine (ISFM) and the American Association of Feline Practitioners (AAFP). JFMS is aimed at both practitioners and researchers with an interest in the clinical veterinary healthcare and welfare of domestic cats, and publishes original papers, short communications and large case series, as well as commissioned state-of-the-art review articles and consensus guidelines.
JFMS has a sister title, the Journal of Feline Medicine and Surgery Open Reports, which is an online, open access journal that publishes high-quality case reports, short case series and short communications reporting regional prevalence data or other data related to well-recognised diseases of domestic cats. Together the two journals provide the ultimate resource for feline medicine and surgery.
This journal is a member of the Committee on Publication Ethics (COPE).
The Journal of Feline Medicine and Surgery (JFMS) is an international journal and authors may discuss products and formulations that are not available or licensed in the individual reader’s own country. Furthermore, drugs may be mentioned that are licensed for human use, and not for veterinary use.
Likewise, in relation to advertising material, it is the responsibility of the reader to check that the product is authorised for use in their own country. Additionally, some products may be advertised that have no veterinary medical licence (eg, nutritional supplements) and may therefore have undergone limited or no testing for safety or efficacy. _ Readers need to bear this in mind and be aware of the prescribing laws pertaining to their own country. _No endorsement is implied in the advertisements included in JFMS.
The authors, editors, owners and publishers do not accept any responsibility for any loss or damage arising from actions or decisions based on information contained in this publication; ultimate responsibility for the treatment of animals and interpretation of published materials lies with the veterinary practitioner. The opinions expressed are those of the authors and the inclusion in this publication of material relating to a particular product, method or technique does not amount to an endorsement of its value or quality, or the claims made by its manufacturer.
JFMS is an international, peer-reviewed journal aimed at both practitioners and researchers with an interest in the clinical veterinary healthcare and welfare of domestic cats. The journal is published monthly in two formats: ‘Classic’ editions containing high-quality original papers on all aspects of feline medicine and surgery, including basic research relevant to clinical practice; and dedicated ‘Clinical Practice’ editions primarily containing opinionated review articles providing state-of-the-art information for feline clinicians, along with other relevant articles such as consensus guidelines.
The aims and scope of JFMS (also, for comparison, its sister journal, JFMS Open Reports) can be viewed here.
Why publish in JFMS?
· Highly respected and Journal Citation Reports indexed journal
· The natural platform for high-quality clinical research and substantial clinical studies contributing novel information in the important field of feline medicine and surgery
· Rigorous peer review
· A timely first decision – on average within 45 days of submission
· Online publication within 20 working days of acceptance
· High quality copyediting and presentation of your article
Which papers are considered for JFMS?
· Original research articles
· Short communications reporting, for example, pilot studies and small studies providing valuable data
· Large prospective case series
· Large retrospective case series
Submissions will be handled simply and efficiently online through SAGE Track, powered by ScholarOne Manuscripts. Submit your manuscript today at http://mc.manuscriptcentral.com/jfms (for full details go to the ‘Submission Guidelines’ tab).
Subscription to JFMS is included as a benefit to members of either ISFM or AAFP. Non-members can receive the journal by joining either society, or by taking out a personal subscription with the publisher SAGE.
Please direct any enquiries to email@example.com
|Margie Scherk||American Association of Feline Practitioners, catsINK, Canada|
|Andy Sparkes||Simply Feline Veterinary Consultancy|
|Claire Bessant||International Society of Feline Medicine, UK|
|Margaret Melling||International Society of Feline Medicine, UK|
|Abi Tansley||International Society of Feline Medicine, UK|
|Hannah Turner||International Society of Feline Medicine, UK|
|Joy Archer||University of Cambridge, UK|
|Esther Barrett||Wales and West Imaging, UK|
|Vanessa Barrs||City University, Hong Kong|
|Julia Beatty||City University, Hong Kong|
|David Bennett||University of Glasgow, UK|
|Nora Berghoff||Michigan State University, USA|
|Jean-Phillipe Billet||Centre Hospitalier Veterinaire Atlanta, France|
|Kieran Borgeat||University of Bristol, UK|
|Dwight Bowman||Cornell University, USA|
|Christopher Byers||CriticalCareDVM.com, USA|
|Martha Cannon||Oxford Cat Clinic, UK|
|Marjorie Chandler||University of Edinburgh, UK|
|Georgina Child||Small Animal Specialist Hospital (SASH), Australia|
|Sandra Corr||University of Glasgow, UK|
|Roswitha Dorsch||Ludwig-Maximilians-Universität München, Germany|
|Pru Galloway||Massey University, New Zealand|
|Laurent Garosi||CVS Referrals, UK|
|Ronette Gehring||Universiteit Utrecht, The Netherlands|
|Danièlle A. Gunn-Moore||University of Edinburgh, UK|
|Joe Hauptman||Okemos, USA|
|Margarethe Hoenig||University of Illinois, USA|
|Ann E. Hohenhaus||The Animal Medical Center, USA|
|Debra F Horwitz||Veterinary Behavior Consultations, USA|
|Linda Jacobson||Toronto Human Society, Canada|
|Rosanne Jepson||Royal Veterinary College, UK|
|Boyd Jones||Massey University, New Zealand|
|Hans Kooistra||Universiteit Utrecht, Netherlands|
|Sorrel Langley-Hobbs||Univeristy of Bristol, UK|
|Michael Lappin||Colorado State University, USA|
|Elizabeth Layne||University of Wisconsin–Madison, USA|
|Loic Legendre||West Coast Veterinary Dental Services, Canada|
|Sally Lester||Pathology Consultant, USA|
|Christine Lim||Eye Care for Animals Chicago, USA|
|Annette Litster||Zoetis, USA|
|Susan Little||Bytown Cat Hospital, Canada|
|Mark Lowrie||Dovecote Veterinary Hospital, UK|
|Leslie A. Lyons||University of Missouri, USA|
|Richard Malik||University of Sydney, Australia|
|Francesca Mancianti||Università di Pisa, Italy|
|Xavier Manteca||Universitat Autonoma De Barcelona, Spain|
|Beatriz P Monteiro||Université de Montréal, Canada|
|Karen Moriello||University of Wisconsin–Madison, USA|
|Jacqueline Norris||University of Sydney, Australia|
|Laura Owen||University of Cambridge, UK|
|Saverio Paltrinieri||Università degli Studi di Milano, Italy|
|Mark G Papich||North Carolina State University, USA|
|Rachel Perry||Perry Referrals, UK|
|Mark Peterson||Animal Endocrine Clinic, USA|
|Alessandro Poli||Università di Pisa, Italy|
|Bruno Pypendop||UC Davis, USA|
|Jessica Quimby||Ohio State University, USA|
|Nicki Reed||Wear Referrals, UK|
|Carol Reinero||University of Missouri, USA|
|Mark Rishniw||Cornell University, USA|
|Bernard Rollin||Colorado State University, USA|
|Angela Witzel Rollins||University of Tennessee College of Veterinary Medicine, USA|
|Stefano Romagnoli||University of Padova, Italy|
|Henrik Rönnberg||Swedish University of Agricultural Science, Sweden|
|Elke Rudloff||Lakeshore Veterinary Specialists, USA|
|Ken Smith||The Royal Veterinary College, UK|
|Samantha Taylor||Lumbry Park Veterinary Specialists, UK|
|Karen Walsh||Eye Veterinary Clinic, UK|
|Craig Webb||Colorado State University, USA|
|Scott Weese||University of Guelph, Canada|
|Kerstin Wildermuth||Tierdermatologie Wildermuth, Germany|
|David Williams||University of Cambridge, UK|
|John Williams||Vets Now, Manchester, UK|
Please read the guidelines below and then visit the Journal’s submission site https://mc.manuscriptcentral.com/jfms to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.
Only manuscripts of sufficient quality that meet the aims and scope of the Journal of Feline Medicine and Surgery will be reviewed.
As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.
- Article types
- Editorial policies
2.1 Peer review policy
2.4 Declaration of conflicting interests
2.6 Clinical and research ethics, and informed consent
2.7 Reporting guidelines
- Publishing policies
3.1 Publication ethics
3.2 Contributor's publishing agreement
3.3 Open Access and author archiving
- Preparing your manuscript for submission
4.2 Artwork, figures, other graphics and tables
4.3 Style guide
4.4 Abbreviations, symbols, and drug names
4.5 Supplementary material
4.6 Reference style
4.7 English language editing services
- Submitting your manuscript
5.2 Information required for completing your submission
- On acceptance and publication
6.1 SAGE production
6.2 Access to your published article
6.3 OnlineFirst publication
- Further information
This Journal is a member of the Committee on Publication Ethics
This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE)
There are no fees payable to submit or publish in this journal.
Please note that manuscripts must be submitted with declaration statements in the following order: Acknowledgements (where relevant), Conflict of Interest, Funding, Ethical Approval and Informed Consent. Manuscripts may be returned if these statements are not included.
Journal of Feline Medicine and Surgery (JFMS) considers manuscripts submitted in the following formats.
Papers should be as concise as possible, and generally not exceed 3,000 words (excluding references). Each paper should have a self-contained Abstract (up to 300 words, structured with subheadings as detailed in Preparing your manuscript), followed by Introduction, Materials and methods, Results, Discussion, Conclusions, Acknowledgements, Conflict of Interest, Funding, Ethical Approval and Informed Consent statements, and References. Note that Original Articles on well-recognised diseases that report valuable national or regional data on disease prevalence, or other relevant data, should be submitted to the sister journal, the Journal of Feline Medicine and Surgery Open Reports (jfmsopenreports.com) as a Short Communication. The manuscript submission guidelines for JFMS Open Reports can be found here.
Offers of reviews and topics for consideration should be directed to the Editors, via the editorial office (firstname.lastname@example.org), for initial editorial approval. Reviews should provide an update on recent advances in a particular field and the length should not generally exceed 4,000 words. They should include an abstract (up to 300 words), followed by subheadings directed by the content, as well as Conclusions, Acknowledgements, Conflict of Interest, Funding, Ethical Approval and Informed Consent statements, and References.
Short communications reporting relevant research or sufficiently substantial pilot studies are considered for JFMS. They should generally not exceed 1,500 words. They should include a self-contained Abstract (up to 300 words, structured with subheadings as detailed in Preparing your manuscript), followed by Introduction, Materials and methods, Results, Discussion, Conclusions, Acknowledgements, Conflict of Interest, Funding, Ethical Approval and Informed Consent statements, and References.
Short Communications on well-recognised diseases that report valuable national or regional data on disease prevalence, or other relevant data, should be submitted to the sister journal, the Journal of Feline Medicine and Surgery Open Reports (jfmsopenreports.com) – the manuscript submission guidelines for which can be found here.
Large prospective and retrospective case series are considered for JFMS. Depending on the information contained, a Case Series may be up to 2,500 words in length. It should include a brief Abstract (up to 300 words structured with subheadings detailed in Preparing your manuscript) followed by Introduction (optional), Case series description, Discussion, Conclusions, Acknowledgements, Conflict of Interest, Funding, Ethical Approval and Informed Consent statements, and References. Small case series and individual case reports that provide novel information should be submitted to the Journal of Feline Medicine and Surgery Open Reports – the manuscript submission guidelines for which can be found here.
Letters to the Editor
Letters commenting on papers recently published in JFMS will be considered for publication in the journal. Letters should not exceed 1,000 words (including references and one table or figure). The Editors may send the letter to the authors of the original paper for comment so that both letter and reply may be published together.
Manuscripts should be clearly labelled ‘Original Article’, ‘Review Article’, ‘Short Communication’, ‘Case Series’ or ‘Letter to the Editor’.
Table 1. Overview of the requirements for manuscript submission to JFMS
Main text word limit
Letters to the Editor
Either one table or figure
*Excludes abstract, references, tables and legends
**Includes references, tables and legends
Journal of Feline Medicine and Surgery Resident Best Paper Award
The award recognises quality and excellence for early career authors who publish in JFMS. Authors who are in a recognised veterinary residency programme (eg, ABVS, EBVS and ANZCVS residency) at the time of submission of their paper will automatically be eligible for consideration for the award, subject to its acceptance for publication. Accepted papers will be considered for the award in the year in which they are published. Details about this award for interested residents and resident supervisors can be found here.
JFMS operates a single-blinded peer review process in which the reviewer’s name is withheld from the author. The reviewer may at their own discretion opt to reveal their name to the author in their review but our standard policy is for the reviewer’s identity to remain concealed. Each manuscript is reviewed by at least two referees. All manuscripts are reviewed as rapidly as possible, and an editorial decision is generally reached within 6–8 weeks of submission. Generally, JFMS does not accept more than two revisions to a paper.
As part of the submission process you will have the option of providing the names of peers who could be called upon to review your manuscript. Recommended reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below:
- The reviewer should have no prior knowledge of your submission
- The reviewer should not have recently collaborated with any of the authors
- Reviewer nominees from the same institution as any of the authors are not permitted
Please note that the Editors are not obliged to invite any recommended reviewers or disregard any opposed reviewers from assessing your manuscript.
Papers should only be submitted for consideration once consent is given by all contributing authors. Corresponding authors should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
- Made a substantial contribution to the concept and design, acquisition of data or analysis and interpretation of data,
- Drafted the article or revised it critically for important intellectual content,
- Approved the version to be published.
- Have participated sufficiently in the work to take public responsibiity for appropriate portions of the content.
Authors should meet the conditions of all of the points above. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship. All contributors who do not meet the criteria for authorship should be listed in the Acknowledgements section (see 2.3 below). Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.
Please note that manuscripts must be submitted with declaration statements in the following order: Acknowledgements (where relevant), Conflict of Interest, Funding, Ethical Approval and Informed Consent. Manuscripts may be returned if these statements are not included.
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help (see also section 2.2).
2.3.1 Third party submissions
Where an individual who is not listed as an author submits a manuscript on behalf of the author(s), a statement must be included in the Acknowledgements section of the manuscript and in the accompanying cover letter. The statements must:
- Disclose this type of editorial assistance – including the individual’s name, company and level of input
- Identify any entities that paid for this assistance
- Confirm that the listed authors have authorized the submission of their manuscript via third party and approved any statements or declarations, e.g. conflicting interests, funding, etc.
Where appropriate, SAGE reserves the right to deny consideration to manuscripts submitted by a third party rather than by the authors themselves.
2.3.2 Writing assistance
Individuals who provided writing assistance (eg, from a specialist communications company) do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance.
It is not necessary to disclose the use of language polishing services.
Any acknowledgements should appear first at the end of your article prior to your Conflict of Interest statement.
2.3.2 Prior presentation at conferences
Details of any prior presentation of study findings/results at conferences or meetings should be included in an 'Author note' section after the 'Acknowledgements' and before the 'Conflict of Interest' statement.
It is the policy of JFMS to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Conflict of Interest’ statement is included at the end of your manuscript, after any acknowledgements and before the 'Funding' statement. If no conflict exists, please state that ‘The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article’.
For guidance on conflict of interest statements, please see the ICMJE recommendations here.
JFMS requires all authors to acknowledge their funding in a consistent fashion under a separate ‘Funding’ heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: ‘The authors received no financial support for the research, authorship, and/or publication of this article.’
Circumstances relating to the use of animals in clinical and experimental studies must meet international standards as set out in:
- The International Guiding Principles for Biomedical Research Involving Animals (1985) from the Council for International Organizations of Medical Sciences, available at https://cioms.ch/shop/product/international-guiding-principles-for-biomedical-research-involving-animals-2/ (or from the Executive Secretary CIOMS, ℅ WHO, Via Appia, CH-1211 Geneva 27, Switzerland)
- The Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals from the International Association of Veterinary Editors, available at http://www.veteditors.org/consensus-author-guidelines-on-animal-ethics-and-welfare-for-editors/
Authors should read the above guidelines prior to undertaking studies and prior to submitting a manuscript to JFMS to ensure standards have been adequately met. The Editors reserve the right to reject papers on ethical or welfare grounds when, in their opinion, studies involve unnecessary pain, distress, suffering, or harm to animals; and where the above guidelines have not been followed.
In addition, the Editors would not normally support publication of:
- Any experimental studies directly resulting in euthanasia of the cats.
- Studies using client-owned cats that may cause the cat a level of pain, suffering, distress or harm higher than that induced by inserting a hypodermic needle, and/or where the procedure is not part of ‘Recognised Veterinary Practice’. Recognised Veterinary Practice would include investigations, procedures and therapies that are part of normal clinical practice and that would be of direct benefit for the individual cat (or potentially to the group to which it immediately belongs). Where investigations, procedures or therapies are unproven, or where there is deliberate exposure of cats to procedures or interventions that might be deleterious to their health without direct clinical benefit to them, it is highly likely that experimental cats should be used with appropriate attention to their health and welfare, and the requisite ethical approval (see below). If authors are in any doubt, they are encouraged to contact the Editors prior to manuscript submission.
In all studies, analgesia, sedation and/or anaesthesia must be used where appropriate, and in such cases the Editors require that authors adequately discuss the use of analgesia for the welfare of the cats involved.
All research involving experimental animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. If no such ethical review body exists, this should be stated and the nature of an ad hoc committee used for this purpose should be described (which must have included at least some individuals independent of the institute(s)/clinic(s) involved in the work).
2.6.1 Ethical Approval
All material published in JFMS must adhere to high ethical standards concerning animal welfare and meet with the above guidelines.
All authors must make one of the following ethical approval declarations on their manuscript, stating:
a) This work involved the use of non-experimental animals only (including owned or unowned animals and data from prospective or retrospective studies). Established internationally recognised high standards (‘best practice’) of individual veterinary clinical patient care were followed. Ethical approval from a committee was therefore not necessarily required.
b) This work involved the use of non-experimental animals only (including owned or unowned animals and data from prospective or retrospective studies). Established internationally high standards (‘best practice’) of individual veterinary clinical patient care were followed. Ethical approval from a committee, while not necessarily required, was nonetheless obtained, as stated in the manuscript.
c) This work involved the use of experimental animals and the study therefore had ethical approval from an established committee as stated in the manuscript. Authors must state in the Materials and Methods the nature of the institutional, national or international ethical review body used, and, if available, the ethical approval number.
d) This work involved the use of non-experimental animals (owned or unowned) and procedures that differed from established internationally recognised high standards (‘best practice’) of veterinary clinical care for the individual patient. The study therefore had ethical approval from an established committee as stated in the manuscript. This statement might, for example, apply to randomised and/or controlled trials (including where established interventions are being compared with each other), as well as studies where novel medications, techniques, devices or interventions not currently part of recognised veterinary practice are used. Authors must state in the Materials and Methods the nature of the institutional, national or international ethical review body used, and, if available, the ethical approval number.
e) This work involved the use of experimental animals but, as no established ethical approval committee was available, an ad hoc ethical committee was used for approval as described in the manuscript. Authors must state in the Materials and Methods the reason why an institutional, national or international ethical review body was not available and should describe the nature of the ad hoc committee used (which must have included at least some individuals independent of the institute(s)/clinic(s) involved in the work).
f) This work involved the use of non-experimental animals (owned or unowned) and procedures that differed from established internationally recognised high standards (‘best practice’) of veterinary clinical care for the individual patient. As no established ethical approval committee was available, an ad hoc ethical committee was used for approval as described in the manuscript. This statement might apply, for example, to randomised and/or controlled trials (including where established interventions are being compared with each other), as well as studies where novel medications, techniques, devices or interventions not currently part of recognised veterinary practice are used. Authors must state in the Materials and Methods the reason why an institutional, national or international ethical review body was not available and should describe the nature of the ad hoc committee used (which must have included at least some individuals independent of the institute(s)/clinic(s) involved in the work).
g) This work did not involve the use of animals and therefore ethical approval was not necessarily required. Authors may select this option if, for example, the manuscript is solely a clinical review or clinical guidelines using previously published data, or presents questionnaire findings, and does not involve the publication of any novel animal data.
2.6.2 Informed Consent and Informed Consent for Publication
All material published in JFMS must include informed consent and meet with the above guidelines. All authors must make an informed consent declaration on their manuscript, stating either:
a) Informed consent (either verbal or written) was obtained from the owner or legal custodian of all animal(s) described in this work (either experimental or non-experimental animals) for the procedure(s) undertaken (either prospective or retrospective studies).
b) This work did not involve the use of animals and therefore informed consent was not required. Authors may select this option if, for example, the manuscript is solely a clinical review or clinical guidelines using previously published data, or presents questionnaire findings, and does not involve the publication of any novel animal data.
In addition to informed consent for use of animals within a study, informed consent for publication is required where any animal, owner and/or other individual may be identifiable as a result of the publication (eg, a recognisable photograph, description or unique identifiable features, etc). Authors are therefore required to state either:
a) For any animals or humans individually identifiable within this publication, informed consent (either verbal or written) for their use in the publication was obtained from the people involved.
b) No animals or humans are identifiable within this publication, and therefore additional informed consent for publication was not required.
Authors and researchers are encouraged to consult the relevant EQUATOR Network reporting guidelines for different studies, including, for example, the Consolidated Standards of Reporting Trials (CONSORT) for randomized controlled trials. Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives
JFMS requests that any primary data used by authors in their research article is published as Supplementary material, or that detailed information is provided in the article on how the data can be obtained. This information should include links to third-party data repositories or detailed contact information for third-party data sources. Data available only on an author-maintained website will need to be loaded onto either the journal’s platform or a third-party platform to ensure continuing accessibility. Examples of data types include (but are not limited to) statistical data files, replication code, text files, audio files, images, videos, appendices, and additional charts and graphs necessary to understand the original research. The Editors may consider limited embargoes on proprietary data. The Editors can also grant exceptions for data that cannot legally or ethically be released. All data submitted should comply with Institutional or Ethical Review Board requirements and applicable government regulations. For further information, please contact Jennie Atkinson (Jennie.email@example.com), Publishing Editor at SAGE Publications.
SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway.
JFMS and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarised other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.
Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive licence agreement, which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the societies. For more information please visit our Frequently Asked Questions.
JFMS offers optional open access publishing via the SAGE Choice programme. For more information please visit the SAGE Choice website. For information on funding body compliance, and depositing your article in repositories, please visit SAGE Publishing Policies.
Authors are responsible for obtaining permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please visit our Frequently Asked Questions.
This section explains how to format, style and reference your paper for JFMS. The title, keywords and abstract are key to ensuring readers find your article online through online search engines such as Google. Please refer to the information and guidance on how best to title your article, write your Abstract and select your keywords by visiting the SAGE Journal Author Gateway for guidelines on How to Help Readers Find Your Article Online.
The preferred format for your manuscript is Word. LaTeX files are also accepted. Word and LaTeX templates are available on the Manuscript Submission Guidelines page of our Author Gateway.
The text should be double-spaced throughout and with a minimum of 3 cm for left and right hand margins and 5 cm at head and foot. Text should be standard 10 or 12 point. All lines should be numbered on manuscripts using continuous line numbering. Figures, tables and Supplementary material should all be cited in the text in numerical order.
The title should be concise with no abbreviations. Please provide the first name, middle initial(s) and surname of each author as well as their department, institution, city and country. Please also provide academic qualifications, email address and full mailing address for the corresponding author to whom proofs should be sent. Please note the email address and full mailing address of the corresponding author will be listed on the first page of an accepted article. A minimum of four keywords (chosen from Index Medicus, Medical Subject Headings if possible) excluding “cat” and “feline” should be listed. Each keyword can be a phrase of up to three words.
The second page of the manuscript must contain only the abstract, which should be of no more than 300 words and must be clearly written and comprehensible to readers before they come to read the paper.
For Original Articles and Short Communications, the Abstract should be structured with the following four subheadings: ‘Objectives’, ‘Methods’, ‘Results’, and ‘Conclusions and relevance’. For Case Series, the abstract should be structured with the following two subheadings: ‘Case series summary’, and ‘Relevance and novel information’.
Abbreviations should be avoided and reference citations are not permitted.
Any manuscripts submitted without a structured abstract will be returned to the author prior to peer review, thus delaying the evaluation process of the manuscript.
For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE's Manuscript Submission Guidelines. Figures supplied in colour will appear in colour online and in print.Tables should be provided in an editable format (eg, drawn in Microsoft Word or Microsoft Excel). The minimum image quality required is 300dpi at 1000 x 1000 pixels.
JFMS has its own style guide: JFMS Style Guide 2020
Do not use propriety symbols (eg, ® or ™) or ltd, etc, in medications or company names.
Medications should be referred to by their recommended International Nonproprietary Name (rINN). A list of these generic names is coordinated by the World Health Organization at http://www.who.int/medicines/services/inn. Where appropriate, the proprietary name and the manufacturer should be given in parentheses when first mentioned; for example:
• carprofen (Rimadyl; Zoetis).
This journal is able to host additional materials online (eg, datasets, podcasts, videos, images, etc) alongside the full-text of the article. These will still be subjected to peer review. For more information please refer to our guidelines on submitting supplementary files.
JFMS adheres to the SAGE Vancouver reference style. View the SAGE Vancouver guidelines to ensure your manuscript conforms to this reference style.
In general only primary sources of information should be cited – citing reviews or book chapters where primary sources are referred to is generally not acceptable. Where relevant, authors should make note of [Abstract] and [Letter] in their references.
Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications may consider using SAGE Language Services. Visit SAGE Language Services for further information.
The following disclaimer appears in print and online.
Journal of Feline Medicine and Surgery is an international journal. Advertising material may promote and/or authors may discuss products and formulations that are not available or licensed in the individual reader’s own country.
Furthermore, drugs may be mentioned that are licensed for human use, and not for veterinary use. Readers need to bear this in mind and be aware of the prescribing laws pertaining to their own country. It is the responsibility of the reader to check that a product is authorised for use in their own country. The authors, Editors, owners and publishers do not accept any responsibility for loss or damage arising from actions or decisions based on information contained in this publication; ultimate responsibility for the treatment of animals and interpretation of published materials lies with the veterinary practitioner. The opinions expressed are those of the authors and/or companies placing advertisements, and the inclusion in this publication of material relating to a particular product, method or technique does not amount to an endorsement of its value or quality, or the claims made by its manufacturer.
JFMS is hosted on SAGE Track, a web-based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit https://mc.manuscriptcentral.com/jfms to login and submit your article online.
IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal since 2011 it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit ScholarOne Online Help.
ORCID applies only to papers published in the Classic editions of JFMS, due to the required verification expected by ORCID.
As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.
The collection of ORCID iDs from corresponding authors is now part of the submission process of this journal. If you already have an ORCID iD you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID iD to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID iD will become part of your accepted publication's metadata, making your work attributable to you and only you. Your ORCID iD is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.
Please note that only ORCID iDs validated prior to article acceptance will be authorised for publication, and we are unable to add or amend ORCID iDs at later stages (eg, at proof stage).
Once an ORCID account is set up you are able to add papers manually to your account to ensure all your work is accounted for. We would recommend this for all papers published in the Clinical Practice editions of JFMS.
You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant). Manuscripts must be submitted with declaration statements in the following order: Acknowledgements (where relevant), Conflict of Interest, Funding, Ethical Approval and Informed Consent.
5.2.1 Social Media - Twitter @CatVets and @ISFMCats
JFMS uses Twitter (through both the ISFM channel @ISFMCats and the AAFP channel @CatVets) to engage with debate on Social Media. Authors and readers are encouraged to join the ongoing discussion around the twitter account on issues related to the Journal. JFMS authors are offered the option of providing their Twitter handle to be published alongside their name and email address within their article. Providing a Twitter handle for publication is entirely optional, if you are not comfortable with JFMS promoting your article along with your personal Twitter handle then please do not supply it.
By providing your personal Twitter handle you agree to let JFMS and SAGE Publications to use it in any posts related to your Journal article. To include your Twitter handle within your article please provide this within the ScholarOne submission form when prompted and on the separate title page in the format outline below (please refrain from adding it to the manuscript itself to facilitate anonymous peer review).
As an example of how to supply this information please see the example below:
Joe Bloggs, Department of Veterinary Science, University Hospital, Town, Zip code, USA
Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be sent by PDF to the corresponding author and should be returned promptly.
SAGE provides authors with online access to their final article.
OnlineFirst allows final revision articles (completed articles in queue for assignment to an upcoming issue) to be published online prior to their inclusion in a final journal issue which significantly reduces the lead time between submission and publication. For more information please visit our OnlineFirst Fact Sheet
Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the JFMS editorial office: firstname.lastname@example.org